← SynDRA
OXYPHENCYCLIMINE
SynDRA canonical compound SYN0007922 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | cholinergic receptor antagonist |
|---|
| Indication | peptic ulcer disease (PUD) |
|---|
| Disease area | gastroenterology |
|---|
All known targets
Mechanisms of action (all sources)
- CHRM3 ANTAGONIST
- Muscarinic acetylcholine receptor M3 antagonist
- CHRM1 ANTAGONIST
- Muscarinic acetylcholine receptor M1 antagonist
- cholinergic receptor antagonist
- CHRM5 BINDER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CHRM2
- KCNH2
- HRH1
- OPRM1
- LMNA
- MAOA
- MC3R
- MC4R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- ADORA1
- HTR2C
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1B1
- SLCO1B3
- SMPD1
- TBXA2R
- HTR3A
- HTR2A
- HTR2B
- CCKAR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM4
- ACM5
- CP2D6
- CP3A4
- CP3A7
- GLI3
- IFNG
- TLR3
ATC classes
- A03A · DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
- ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS
Cross-references
Synonyms
- DARICON
- oxyphencyclimine monohydrochloride
- daricon
- oxyphencyclimine hydrochloride
- oxyphencyclimine HCl
- Oxifenciclimina
- Antulcus
- Caridan
- Daricol
- Manir
- Naridan
- Oxifencicliminum
- Oxiphencycliminum
- Oxyphencycliminum
- Zamanil
- Oxifencicliminum [INN-Spanish]
- Oxyphencyclimine (INN)
- Oxyphencyclimine [INN:BAN]
- Oxyphencycliminum [INN-Latin]
- 4V44H1O8XI
- CHEBI:7868
- OXYPHENCYCLIMINE [INN]
- EINECS 204-743-3
- UNII-4V44H1O8XI
- Setrol (Salt/Mix)
- Daricol (Salt/Mix)
- Daricon (Salt/Mix)
- Spectrum_001606
- Vio-thene (Salt/Mix)
- Spectrum2_001600
- Spectrum3_001806
- Spectrum4_000234
- Spectrum5_001499
- Ulcociclinina (Salt/Mix)
- CHEMBL1495
- BSPBio_003391
- KBioGR_000927
- KBioSS_002086
Look up OXYPHENCYCLIMINE in the interactive SynDRA portal →